Holen Sie sich die Stockscreener-App
107.17
0.70%
-0.68
Schlusskurs vom Vortag:
$107.85
Offen:
$107.43
24-Stunden-Volumen:
39,682
Relative Volume:
0.22
Marktkapitalisierung:
$2.43B
Einnahmen:
$240.87M
Nettoeinkommen (Verlust:
$53.34M
KGV:
46.12
EPS:
2.3238
Netto-Cashflow:
$66.23M
1W Leistung:
+17.19%
1M Leistung:
+23.39%
6M Leistung:
+10.32%
1J Leistung:
+18.37%
1-Tages-Spanne:
$106.17
$108.19
1-Wochen-Bereich:
$100.37
$115.33
52-Wochen-Spanne:
$71.42
$115.33
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
106.97 | 2.45B | 240.87M | 53.34M | 66.23M | 2.3238 |
|
ISRG
Intuitive Surgical Inc
|
504.60 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.32 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.73 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.41 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.30 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LeMaitre Vascular Hits Day High with 24.41% Surge in Stock Price - Markets Mojo
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat
LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
LeMaitre Vascular Hits New 52-Week High at $115.33, Up 46.41% - Markets Mojo
LeMaitre Vascular Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Buy Ratings Amid Steady Revenue Growth - DirectorsTalk Interviews
LeMaitre (LMAT) director Roush gains 476 shares from PSU vesting - Stock Titan
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock By Investing.com - Investing.com India
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock - MarketBeat
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com
LeMaitre Vascular (LMAT) president reports sale of 8,464 shares - Stock Titan
LeMaitre Vascular (LMAT) director gains stock through PSU vesting and dividend rights - Stock Titan
LMAT (LMAT) CEO LeMaitre reports 205,930-share sale, PSU vesting and gift - Stock Titan
George W. LeMaitre sells 150,000 shares (LMAT) in Form 144 - Stock Titan
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? - Yahoo Finance
LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross - Bitget
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance
LeMaitre Vascular Signals Confident Growth in Earnings Call - The Globe and Mail
LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory - Yahoo Finance
LMAT: Morgan Stanley Smith Barney files Form 144 for vested restricted shares (LMAT) - Stock Titan
LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT) - Seeking Alpha
LeMaitre to Participate at Upcoming Investor Conferences in March - marketscreener.com
Five investor conferences spotlight LeMaitre in busy March - Stock Titan
[144] LEMAITRE VASCULAR INC SEC Filing - Stock Titan
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2025 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play? - TIKR.com
LeMaitre Vascular Q4 2025 Earnings: Revenue & Profit Exceed ExpectationsNews and Statistics - IndexBox
LeMaitre Vascular stock reaches 52-week high at 103.05 USD By Investing.com - Investing.com Australia
LeMaitre Vascular (LMAT) Gets Price Target Boost from Barrington Research | LMAT Stock News - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $105.00 - MarketBeat
LeMaitre Vascular Q4 2025 Earnings Beat, Provides Strong 2026 OutlookNews and Statistics - IndexBox
LeMaitre Sees Growth Surge with Promising Earnings, Revenue Outlook - StocksToTrade
Roth Mkm Reaffirms Buy Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat
Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views - Benzinga
LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results - marketscreener.com
LeMaitre (LMAT) Stock Trades Up, Here Is Why - Finviz
LMAT Price Target Raised by Wells Fargo | LMAT Stock News - GuruFocus
Wells Fargo & Company Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price - MarketBeat
LMAT: Citizens Raises Price Target to $118, Maintains Market Out - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High After Strong Earnings - MarketBeat
Barrington Adjusts Price Target on LeMaitre Vascular to $105 From $95, Maintains Outperform Rating - marketscreener.com
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
LeMaitre Vascular stock reaches 52-week high at 103.05 USD - Investing.com
Income Plays: Is LeMaitre Vascular Inc stock a value trapJuly 2025 Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
LEMAITRE VASCULAR INC SEC 10-K Report - TradingView
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):